Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Sarepta Therapeutics (NASDAQ: SRPT)

$32.86 USD $0.59 (1.83%)
Last Price $32.86
Net Change $0.59 (1.83%)
Bid $32.84
Ask Price $32.88
Open Price $32.33
Previous Close Price $32.27
High Price $32.86
Low Price $31.5
Number of Trades 4,125
Volume 724,135
Fifty Two Week High $63.73 (2016-09-28)
Fifty Two Week Low $14.83 (2016-06-02)
Average Daily Volume 2,375,904
Share Outstanding 54,960 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.6 (2017-04-27)
2nd Quarter Earnings $-0.71 (2017-02-28)
3nd Quarter Earnings $-0.95 (2016-10-27)
4th Quarter Earnings $-1.19 (2016-07-19)
PE Ratio $0
EPS Growth $44.66
Recent Earnings $-0.6
Annual EPS $-4.75
Last Quarter EPS $
Market Capitalization $1.81B
Insider Shareholders % 0.096%
Annual Revenue $0B
No. Shares Outstanding 54,960
Inst. Shareholder % 73.85%
Annual Net Income $-0.12B
TTM Net Profit Margin $-567.1
1-Year Return 75%
3-Year Return -7.48%
5-Year Return 646.99%
5-Year Revenue Growth -88.47%
5-Year Earnings Growth 4400%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 44.66%
Dividends per Share $
Stock Split Ratio 1-6
Beta 1.48
Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy. Sarepta Therapeutics, Inc., formerly known as AVI BioPharma, Inc., is headquartered in Bothell, Washington.